Cerus prices underwritten public offering

Cerus Corporation (NASDAQ:CERS) today announced the pricing of an underwritten public offering of 7,368,422 units, with each unit consisting of one share of its common stock and a warrant to purchase 0.5 of a share of its common stock, at a price to the public of $2.85 per unit. The aggregate public offering price of this offering is approximately $21.0 million, and the net proceeds to the Company, after deducting underwriting discounts and commissions, but before legal and other estimated offering expenses, are expected to be approximately $19.7 million. The offering is expected to close on or about November 15, 2010, subject to customary closing conditions. Each warrant will have an exercise price of $3.20 per share, will be exercisable six months after the date of issuance and will expire five years from the date of issuance. The shares of common stock and the warrants are immediately separable and will be issued separately.

Jefferies & Company, Inc. is acting as sole book-running manager for the offering and Robert W. Baird & Co. Incorporated is acting as co-lead manager for the offering. Cerus anticipates using the net proceeds from the offering for general corporate purposes, including research and development expenses, selling, general and administrative expenses and manufacturing expenses. In addition, Cerus may use a portion of the net proceeds for the repayment of indebtedness.

The securities described above are being offered by Cerus pursuant to a shelf registration statement previously filed with the Securities and Exchange Commission (the "SEC"), which the SEC declared effective on December 17, 2008.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.